The invention relates to compounds of formula I
and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimmune diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
本发明涉及公式I的化合物及其药学上可接受的盐、前药、溶剂或
水合物。本发明还涉及使用这种化合物治疗哺乳动物(尤其是人类)的增殖过度性疾病和自身免疫性疾病的方法,以及含有这种化合物的药物组合物。